Author: Balraj Juttla

US and UK cosmetic procedure volumes maintain buoyancy

Breast implants have been the focus of much attention recently, mainly for the wrong reasons. But confidence in the market remains high, as 2011 procedure volumes in the UK and US show. The UK’s BAAPS president‑elect, Rajiv Grover, and the US ASPS president, Malcolm Roth, give their views on general business trends to Ashley Yeo

Read More

Douglas Ingram: Allergan

In the post-PIP era, the medical aesthetics industry can expect to be dogged by issues of trust and quality. Rosalind Hill speaks to Douglas Ingram about how Allergan plans to address these questions head-on

Read More

Elena Baranova: Baranova Monaco

Genetic research and innovation has had a profound impact on aesthetic and anti-ageing medicine over the past 10 years. Rosalind Hill speaks to Elena Baranova about the continuing development of this area

Read More

Think globally, market locally

Keep it simple by staying true to your brand when marketing your aesthetic clinic. Wendy Lewis explains why big brand strategies don’t apply to small businesses

Read More

Finding a new niche in fungal nail treatment

The fungal nail market, worth $1 billion globally, has been under-served — and for clear reasons, says Moberg Derma CEO, president and co-founder Peter Wolpert. With new technologies and an original business model, the Swedish company aims to change that, he tells Ashley Yeo

Read More